Key result
Surgery for infective endocarditis after TAVR in 10 high-risk patients resulted in 1 in-hospital death, with all 9 discharged patients surviving during a mean follow-up of 9 months.
Why the study?
Increasing use of TAVR has expanded the population with aortic-valve prostheses, leading to a rising incidence of prosthetic-valve endocarditis.
Is surgical therapy feasible and safe for patients developing infective endocarditis after TAVR?
Population
10 patients undergoing surgery for prosthetic-valve endocarditis after TAVR
Design
Retrospective single-center analysis
Follow-up
Mean 9 ± 8 month
Authors
Loading...
May support surgery in select high-risk post-TAVR IE cases; hypothesis-generating and requires larger prospective validation.
Observational (n=10)
No
Is surgical therapy feasible and safe for patients developing infective endocarditis after TAVR?
Surgical therapy for infective endocarditis after TAVR is feasible and yields good survival outcomes despite the high baseline surgical risk of these patients.
Rösch et al. (2023) conducted an observational in Prosthetic-valve endocarditis after TAVR (n=10). Surgery for prosthetic-valve endocarditis was evaluated on In-hospital mortality. Surgery for infective endocarditis after TAVR in 10 high-risk patients resulted in 1 in-hospital death, with all 9 discharged patients surviving during a mean follow-up of 9 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: